Related Experiment Video

Updated: Jun 11, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation

Dan Yan1, Wooi Loon Ng, Xiangming Zhang

  • 1Department of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia, United States of America.

Plos One
|July 10, 2010
PubMed
Abstract

Insights

Researchers identified microRNAs (miRNAs) targeting DNA repair genes as a novel strategy to enhance radiotherapy effectiveness. Upregulating miR-101 sensitized tumor cells to radiation by reducing DNA repair proteins, offering a new approach for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Radiotherapy combats cancer by inducing DNA double-strand breaks (DSBs), but tumor repair mechanisms often limit treatment efficacy.
  • Developing effective radiosensitizers is crucial for improving cancer treatment outcomes.
  • This study investigates targeting DNA DSB repair genes with microRNAs (miRNAs) as a novel radiosensitization strategy.

Purpose of the Study:

  • To explore the potential of miRNAs in targeting DNA double-strand break repair genes for radiosensitization.
  • To identify specific miRNAs that can modulate key DNA repair pathways in tumor cells.

Main Methods:

  • Utilized database searches and experimental validation to identify miRNAs targeting DNA-PKcs and ATM, key DNA repair and checkpoint genes.
  • Investigated the binding of identified miRNAs to the 3'-untranslated region (UTR) of target mRNAs.
  • Assessed the effect of miRNA upregulation on protein levels of DNA repair factors and tumor cell radiosensitivity in vitro and in vivo.

Main Results:

  • miR-101 was identified as a miRNA that directly targets both DNA-PKcs and ATM by binding to their 3'-UTRs.
  • Upregulation of miR-101 led to decreased protein expression of DNA-PKcs and ATM in tumor cells.
  • Enhanced miR-101 levels significantly sensitized tumor cells to ionizing radiation, both in vitro and in vivo.

Conclusions:

  • Demonstrates for the first time that miRNAs can effectively target DNA repair genes to enhance tumor radiosensitivity.
  • Presents a novel therapeutic strategy utilizing miRNAs for improving the efficacy of radiotherapy in cancer treatment.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...